Russia and China to Build a New Pharmaceutical Plant in the Irkutsk Region
Russia and China continue to strengthen economic cooperation in the high-tech sector. It was recently announced that a new large-scale production facility for pharmaceutical substances will be established in the Irkutsk region. This project will be an important step for the development of medicine and industry in the eastern part of the country.
The project is being implemented through the joint efforts of a Russian pharmaceutical company and its Chinese partner. The total investment in the new enterprise will exceed 13 billion tenge (approximately 2.7 billion rubles). These funds will be used for the construction of modern workshops and the installation of high-tech equipment for creating medicinal components.
The main task of the new plant is the production of pharmaceutical substances. This is the primary raw material required for the production of finished medicines. Developing such production within the country will help provide pharmacies and hospitals with necessary drugs and significantly reduce dependence on foreign raw material supplies.
The construction of the plant in Irkutsk will also have a positive impact on the region's economy. It is expected that the project will create hundreds of new jobs for qualified specialists: chemists, technologists, and engineers. This will provide young professionals with the opportunity to work in their home region on important scientific and industrial tasks.
In the future, the new Russian-Chinese enterprise could become one of the key players in the pharmaceutical market. The launch of the plant will not only strengthen business ties between the two countries but also make high-quality medical care more accessible to the residents of Russia.